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In the adult hippocampus, neuroprogenitor cells in
the subgranular zone (SGZ) of the dentate gyrus
give rise to newborn neuroblasts. However, only
a small subset of these cells integrates into the
hippocampal circuitry as mature neurons at the end
of a 4 week period. Here, we show that the majority
of the newborn cells undergo death by apoptosis in
the first 1 to 4 days of their life, during the transition
from amplifying neuroprogenitors to neuroblasts.
These apoptotic newborn cells are rapidly cleared
out through phagocytosis by unchallenged microglia
present in the adult SGZ niche. Phagocytosis by the
microglia is efficient and undeterred by increased
age or inflammatory challenge. Our results suggest
that the main critical period of newborn cell survival
occurs within a few days of birth and reveal a new
role for microglia in maintaining the homeostasis of
the baseline neurogenic cascade.
INTRODUCTION
Microglia are the brain immune cells, responsible for orches-
trating the brain innate immune response. They belong to the
monocytic-macrophage lineage (Ajami et al., 2007) and are
therefore natural-born, professional phagocytes (Mallat et al.,
2005). During development, microglia play an essential role by
phagocytosing the excess of neuroblasts, such as in the cere-
bellum (Marı´n-Teva et al., 2004). In the adult brain, microglia
have been mostly studied in the context of disease, when
they become activated or challenged by pathological condi-
tions. Activated microglia are hypertrophic or amoeboid-like
(Aloisi, 2005); they initiate an inflammatory response through
the secretion of proinflammatory cytokines (Aloisi, 2005) and
phagocytose dying cells (Kettenmann, 2007). Recently, it has
been suggested that microglia play a role in adult neurogenesis,
such as when activated by inflammation (Butovsky et al., 2006;
Ekdahl et al., 2003a; Monje et al., 2003) or by adrenalectomy
(Battista et al., 2006), or when neurogenesis was induced by
enriched environment (Ziv et al., 2006). However, the potentialCrole of microglia in adult neurogenesis in normal conditions
remains unknown.
One of the important issues in neurogenesis, both during
development and in the adult brain, is the survival of the newborn
cells. In the subgranular zone (SGZ) of the dentate gyrus, where
neurogenesis occurs throughout adulthood, only a few newborn
cells are incorporated into the circuitry, and the majority of
them are presumed to die at the immature neuron stage (Ma
et al., 2009). However, a sharp decline in the number of newborn
cells, labeled with the thymidine analog 5-bromo-20-deoxyuri-
dine (BrdU), occurs much earlier (Kempermann et al., 2004; Kro-
nenberg et al., 2003; Mandyam et al., 2007). Furthermore, it has
not been firmly established that this decline in the number of the
BrdU-immunopositive cells is due to apoptosis. Apoptosis of
newborn cells is hard to evaluate and initial studies provided
only qualitative evidence (Biebl et al., 2000; Dayer et al., 2003;
Kuhn et al., 2005). The cell survival is essential for regulation
of the neurogenic cascade, so we sought to define the critical
period of survival of newborn cells in the adult hippocampus
and the clearing mechanism that removes the apoptotic debris.
Based on published data of BrdU decay (Kempermann et al.,
2004; Kronenberg et al., 2003; Mandyam et al., 2007), we
hypothesized that newborn cells undergo apoptosis mostly
during an early critical period and that the apoptotic debris is
removed from the SGZ neurogenic niche by microglia. In most
tissues, apoptotic cells are phagocytosed within 1–2 hr from
the start of apoptosis (Savill, 1997). Thus, if microglial phagocy-
tosis in the healthy adult brain is similarly rapid, the probability of
detecting apoptotic newborn cells would be low, explaining the
difficulty in obtaining quantitative data on apoptosis and phago-
cytosis. Herein, we addressed this issue by investigating phago-
cytosis of the apoptotic cells in the healthy SGZ neurogenic
niche, performed by ‘‘unchallenged’’ microglia. The unchal-
lenged microglia we refer to are ramified microglia in normal
conditions, where there are no exogenous challenges, but only
the local signals regulating their behavior and function.
We found that unchallenged microglia are indeed an essential
component of the normal hippocampal neurogenic niche and are
involved in phagocytosing apoptotic newborn cells. In addition,
we show that the main critical period of survival of young adult
SGZ newborn cells occurs early in the cell life, during the transi-
tion from late amplifying neuroprogenitors (ANPs) to neuroblasts
(NBs). Our data suggest that apoptosis in the first 4 days of
cell life followed by microglial phagocytosis accounts for theell Stem Cell 7, 483–495, October 8, 2010 ª2010 Elsevier Inc. 483
Figure 1. Apoptosis Is Coupled to Phagocy-
tosis in the Young Adult SGZ
(A) Confocal photomicrographs of apoptotic cells
in the young adult (1 m.o.) SGZ. Apoptotic cells
(arrowheads), detected by pyknosis/karyorrhexis
(condensed DAPI staining) and act-casp3, are
predominantly located in the SGZ (A1) and more
sparsely in the granular cell layer (A2) and hilus
(A3). Apoptotic cells in (A1) and (A2) are engulfed
by microglia visualized in fms-EGFP mice.
(B) Quantification of the location of apoptotic cells,
identified by pyknosis and act-casp3 expression,
in the hippocampus. The vastmajority of apoptotic
cells is located strictly in the SGZ.
(C) Different stages of phagocytosis in the SGZ.
The microglial engulfment of apoptotic cells (py-
knotic, act-casp3 immunopositive) was assessed
in orthogonal projections of confocal z-stacks.
Apoptotic cells are either not phagocytosed (C1);
undergoing early phagocytosis (loose microglial
pouch, conspicuous act-casp3 immunolabeling;
C2); or undergoing late phagocytosis (tight micro-
glial pouch, dim act-casp3 immunolabeling; C3).
(D) Quantification of the phagocytic index (Ph-
index), i.e., the percentage of SGZ apoptotic cells
that are engulfed by microglia (early and late
phagocytosis together), in three independent
experiments. A large percentage (>90%) of
the apoptotic cells is completely engulfed by
microglia.
(E) Confocal photomicrographs of the SGZ
showing Iba+ microglial processes and somas
intermingled with the SGZ NPCs (nestin-GFP+)
and NBs (PSA-NCAM+). DAPI staining indicates
cell nuclei. The arrowhead points to an apoptotic
(pyknotic) cell, identified by condensed DAPI
staining, that expresses PSA-NCAM and is
engulfed by the microglial process.
Scale bars represent 10 mm in (A) and (C) and
20 mm in (E). See also Figure S1. Bars represent
mean ± SEM.
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Apoptosis/Phagocytosis in Hippocampal Neurogenesisdecay in the number of newborn cells in the young adult SGZ
and provide a new role for unchallenged microglia in adult
neurogenesis.
RESULTS
Apoptosis Is Coupled to Phagocytosis in the Young
Adult SGZ
We first analyzed the distribution of apoptotic cells within the
hippocampal neurogenic niche, in the young adult (1-month-
old [m.o.]) mouse (Figures 1A and 1B). Apoptosis is character-
ized by specific nuclear morphology such as pyknosis (DNA
condensation) and karyorrhexis (nuclear fragmentation), both
detected by condensed staining with DAPI, a DNA dye (Fig-
ure 1A; Savill et al., 2002). Pyknotic nuclei are clearly distin-
guished from the nuclei of other healthy cells, such as neuronal
(with puncta of bright heterochromatin) and endothelial (crescent
shape), as well as from cells in mitosis (in which the separating484 Cell Stem Cell 7, 483–495, October 8, 2010 ª2010 Elsevier Inc.chromosomes can be observed) (Figure S1 available online). In
addition, apoptosis is functionally characterized by activation
of caspase 3 (act-casp3) (Nicholson et al., 1995), which cleaves
b-actin, resulting in a fragment called fractin (Figure 1A;
Figure S1; Yang et al., 1998). In the young adult SGZ, 100% of
the cells labeled with act-casp3 antibody (181/181 cells, n = 5)
or fractin antibody (151/151 cells, n = 3) are also identified as py-
knotic. More than 90% of the apoptotic cells (pyknotic/karyor-
rhectic, act-casp3+) are located strictly in the SGZ (Figures 1A
and 1B), defined as a layer of cells expanding 5 mm into the hilus
and 15 mm into the granular cell layer. Apoptotic cells are rarely
found in the hilus, granular, or molecular layers (Figures 1A and
1B), as reported (Biebl et al., 2000). The abundance of apoptotic
cells within the SGZ neurogenic niche suggests their relationship
with the neurogenic cascade (Biebl et al., 2000), and herein we
investigate their identity and the clearing mechanism.
We hypothesized that the apoptotic cells in the normal young
adult SGZ were removed through phagocytosis performed by
Cell Stem Cell
Apoptosis/Phagocytosis in Hippocampal Neurogenesisresident microglia. To identify microglia, we used immunofluo-
rescent labeling with an antibody against Iba-1 (ionized calcium
binding adaptor molecule 1, a marker of the macrophage
lineage) in wild-type animals or transgenic fms-EGFP mice
(in which the regulatory elements of the macrophage colony-
stimulating factor receptor gene drive EGFP expression), where
EGFP is expressed by microglia (Sierra et al., 2007). Iba1 and
EGFP are both expressed throughout the cytoplasm, and thus
outline both the cell body and the processes of microglia. The
relationship between the apoptotic profiles and microglia in the
normal young adult SGZ can be classified into three main cate-
gories: not phagocytosed, early phagocytosis, or late phagocy-
tosis (Figure 1C; Figure S1). Some pyknotic cells labeled with
act-casp3 were not in the vicinity of a microglial cell (Figure 1C1;
not phagocytosed), whereas others were being approached
by a microglial process (Figure S1D1). In other instances, apo-
ptotic cells were completely engulfed by microglia (Figure 1C2)
and had conspicuous act-casp3 labeling and a loose, patchily
stained microglial phagocytic pouch, suggesting that phagocy-
tosis was recently initiated (early phagocytosis). Another cate-
gory of cells showed faint act-casp3 labeling and a tight micro-
glial pouch, indicating that phagocytosis was almost complete
(Figure 1C3; late phagocytosis). Occasionally, puncta of act-
casp3 were seen within the microglial processes and diminutive
DAPI or BrdU particles within a microglial pouch (Figure S1),
appearing to be in the terminal stages of phagocytosis.
The efficiency of the microglial phagocytosis is determined by
the phagocytic index (Ph-index), the percentage of the apoptotic
cells undergoing microglial phagocytosis (early and late phago-
cytosis combined). In the adult SGZ, microglia phagocytose
91.0% ± 3.1% of the pyknotic cells (266/287 cells, n = 10 wild-
type mice), 91.6% ± 3.5% of the pyknotic, act-casp3 immunore-
active cells (169/181 cells, n = 5 fms-EGFP mice), and 94.4% ±
2.4% of the pyknotic, fractin immunoreactive cells (143/151
cells, n = 3 fms-EGFP mice) (Figure 1D; Table S1). There are
no significant differences in the Ph-index (ANOVA, p = 0.815)
among the three methods used for detecting apoptosis. The
remaining 5%–8% of apoptotic cells not phagocytosed by
microglia were always in the earliest stages of apoptosis (large
pyknotic body, high expression of act-casp3 or fractin; Fig-
ure 1C1; Figure S1), suggesting that the phagocytic process
has not yet begun.
Phagocytosis of the apoptotic cells is performed by ramified
microglia in the SGZ neurogenic niche, where their processes
intermingle among quiescent and amplifying neuroprogenitors
(NPCs) and neuroblasts (NBs) (Figure 1E). NPCs were visualized
in nestin-GFP transgenic mice, which express GFP under
the nestin promoter and regulatory elements (Mignone et al.,
2004). NBs were visualized by immunolabeling with an antibody
raised against PSA-NCAM, the polysialated form of the neural
cell adhesion molecule, expressed in migrating newborn cells
committed to the neuronal fate. To determine the extent of the
microglial presence in the niche, we quantified the percentage
of NPCs and NBs contacted by microglia (Figure S2). Approxi-
mately one-third (37% ± 4%) of the NPCs and 30% ± 3% of
the NBs are in contact with microglial processes (n = 4). In the
majority of cases, the contacts are tangential, and only occa-
sionally, the microglial cell body is apposed to the NPCs or
NBs cell body (Figure S2). These data indicate a complex spatialCrelationship between NPCs/NBs and microglia and provide
the anatomical support for our hypothesis that unchallenged
microglia efficiently phagocytose newborn cells in the normal
adult SGZ.
Unchallenged Microglia Phagocytose Apoptotic Cells
in the Normal Adult SGZ
The phagocytic microglia shows ramified morphology typical of
unchallenged microglia. To further confirm this observation, we
tested the expression of two markers that increase upon micro-
glial activation: CD11b (integrin a M) and CD68 (macrosialin)
(Ekdahl et al., 2003a). Their expression in SGZ phagocytic micro-
glia was compared to their expression in nonphagocytic micro-
glia from the CA2 hippocampal region, as a negative control (Fig-
ure 2A; Figure S2). As a positive control, we analyzed their
expression in SGZ microglia of animals treated with bacterial
lipopolysaccharides (LPS) (Figure 2A; Figure S3), which induce
an inflammatory challenge and activate microglia (Sierra et al.,
2007). The expression of markers in SGZ phagocytic microglia
(CD11blow, CD68low) is similar to that of CA2 nonphagocytic
microglia and dramatically different from that of microglia chal-
lenged with LPS (CD11bhigh, CD68high) (Figure 2A; Figure S2).
These data thus suggest that phagocytosis does not activate
microglia the same way an inflammatory challenge does, pro-
viding functional evidence that SGZ microglia phagocytos-
ing apoptotic cells in physiological conditions are indeed
unchallenged.
Phagocytosis by unchallenged microglia occurs by a special
modification of the microglial processes, which form a phago-
cytic pouch that engulfs the apoptotic cell, as shown by volume
rendering of phagocytic SGZ microglia in confocal z-stacks
(Figure 2B). The phagocytic pouches take on a ball-and-chain
structure connected with the microglial cell body at a terminal
or en passant branch (Figure 2B), clearly distinguishable from
the microglial body. Finally, the phagocytosis of apoptotic cells
by microglia in the normal young adult SGZ is also observed at
the ultrastructural level (Figure 2C). Microglial processes were
labeled with antibodies against Iba1 and revealed by peroxidase
staining. Two examples of pyknotic nuclei engulfed by microglial
processes in the SGZ are shown in Figure 2C. Taken together,
the above results indicate that unchallengedmicroglia are largely
responsible for recognizing and eliminating apoptotic cells in
the young adult SGZ during healthy conditions.
Identity of the Phagocytosed Apoptotic Cells
To determine the cellular identity of the apoptotic cells being
phagocytosed by microglia, we utilized antibodies for most of
the cell types present in the SGZ (Figure 3; Figure S3,
Table S2). We find that 8% ± 4%of the total number of apoptotic
cells are only nestin-GFP+; 42% ± 11% are only PSA-NCAM+;
and 17% ± 4% express both nestin-GFP and PSA-NCAM (n = 4
mice). 28% ± 6% of the apoptotic cells express POMC-EGFP,
a marker of postmitotic differentiating newborn neurons (Over-
street et al., 2004) (n = 6 mice), while none express doublecortin,
a marker of NBs (DCX; n = 6 mice). None of the SGZ apoptotic
cells express NeuN (a marker of immature and mature neurons)
and only 5% dimly express Prox1 (a specific marker of gran-
ule cells expressed in early stages of neuronal differentiation)
(n = 3 mice). In addition, no apoptotic astrocytes or quiescentell Stem Cell 7, 483–495, October 8, 2010 ª2010 Elsevier Inc. 485
Figure 2. UnchallengedMicroglia Phagocy-
tose Apoptotic Cells in the Normal Adult
SGZ
(A) Confocal photomicrographs of the expression
of CD11b and CD68 in phagocytic microglia.
Phagocytic SGZ and nonphagocytic CA2 micro-
glia express low levels of CD11b and CD68,
whereas LPS-challenged microglia express high
levels of these markers (n = 3 fms-EGFP mice;
LPS 5 mg/kg, 24 hr). The expression of fms-
EGFP is similar in all experimental groups studied.
Identical confocal settings were used to collect
images from all animals. Enlarged insets of the
merged images are shown at the end of each
row. See also Figure S2.
(B) Phagocytosis by microglia involves a ball-and-
chain structure, formed bymicroglial en passant or
terminal branches clearly distinguishable from
the microglial cell body (M), as shown in volume
rendering images of confocal z-stacks. The micro-
glial phagocytic pouch in (B1) (arrowhead) is
shown in detail in (B2): a pyknotic nucleus located
on top of a PSA-NCAM+ NB and nearby nestin-
GFP+ NPC is undergoing phagocytosis. The right
microglial phagocytic pouch in (B3) (arrowhead)
is shown in detail in (B4): a pyknotic nucleus
located among immature and mature neurons
(labeled with Prox1 and NeuN, respectively) is
undergoing phagocytosis.
(C) Electronmicrographs of the apoptotic cells and
phagocytosis by microglia in the young adult SGZ.
(C1), Microglia (M), detected by Iba1-DAB immu-
nostaining, is intermingled among the SGZ cells;
(C2), apoptotic cell (Pyk), identified by nuclear
morphology, is engulfed by microglia (M); (C3),
terminal apoptotic debris is engulfed by microglia
(M). (C4), enlarged region of interest from (C3).
Scale bars represent 20 mm in (A) (z = 10 mm);
10 mm in (B); 5 mm in (C1)–(C3); and 500 nm in
(C4). Arrowheads, phagocytic pouches; M, micro-
glia; h, hilus; Pyk, pyknotic body; As, astrocyte.
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mice), in which EGFP is expressed under the control of the
human GFAP promoter (glial fibrillary acidic protein) (Zhuo
et al., 1997). We, however, observed a small percentage of
apoptotic endothelial cells (4% ± 2%) labeled with PECAM1 (n
= 4 mice). Finally, no apoptotic cells express myelin binding
protein (MBP), a marker of oligodendrocytes (n = 3 mice), or
GFAP via a GFAP antibody (n = 3 mice). We also did not observe
apoptotic cells being engulfed by GFAP+ or hGFAP-GFP+ astro-
cytes. Thus, although astrocytes have been implicated in the
phagocytosis of synaptic membranes during synaptic remodel-
ing (Aldskogius et al., 1999), our results exclude them from play-
ing a significant role in phagocytosing apoptotic cells in the
normal young adult SGZ.
Interestingly, up to 32% ± 5% (n = 4 nestin-GFP mice) of the
apoptotic profiles could not be identified with any of the markers
we used. The majority (79% ± 10%) of these unidentified cells486 Cell Stem Cell 7, 483–495, October 8, 2010 ª2010 Elsevier Inc.are strictly located within the physical niche formed by nestin-
GFP+ NPC processes, as well as POMC-EGFP+ NB processes
(Figure S3), suggesting their relationship with the neurogenic
cascade despite their lack of immunolabeling with the tested
biomarkers. Nonetheless, the expression of biomarkers in apo-
ptotic cells should be taken cautiously, because our ability to
detect them depends on the expression levels of the protein or
the transgene and their rate of degradation, both internally by
caspases or externally by microglia. Overall, our results suggest
that the majority of the apoptotic cells in the normal young adult
SGZ are part of the neurogenic cascade and belong to a transi-
tional stage between late ANPs and early NBs.
Newborn Cells Undergo Early Apoptosis
The number of BrdU-labeled newborn cells in the SGZ declines
dramatically during the first week of their life (Kempermann et al.,
2004; Kronenberg et al., 2003; Mandyam et al., 2007). Based on
Figure 3. Cell Identity of the SGZ Apoptotic
Cells
Confocal orthogonal projections of apoptotic
cells, identified by pyknosis/karyorrhexis, express
different cell type-specific biomarkers in the young
adult neurogenic SGZ. Low-magnification images
of all immunolabeling data can be found in
Figure S3.
(A) Apoptotic cell expressing nestin-GFP.
(B) Apoptotic cell expressing PSA-NCAM.
(C) Apoptotic cell expressing nestin-GFP and
PSA-NCAM.
(D) Apoptotic cell expressing POMC-EGFP but
not DCX.
(E) Apoptotic cell expressing Prox1 but not NeuN.
(F) Apoptotic cell expressing PECAM1 but not
hGFAP-GFP. A capillary with PECAM1+ endothe-
lial cell surrounded by hGFAP-GFP+ astrocytic
terminal feet is nearby (arrows).
(G) Apoptotic cell not expressing either MBP or
GFAP.
(H) Fraction of SGZ apoptotic cells expressing
each of the different cell type markers shown
above. The majority of the apoptotic cells
expresses markers of cells found in early stages
of the neurogenic cascade.
Scale bars represent 10 mm. ND, nondetectable.
Bars represent mean ± SEM. Arrows, capillary.
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apoptosis of newborn cells, and we tested it in a BrdU pulse-
and-chase experiment. 1-month-old mice received a single
dose of BrdU (250 mg/kg) and were sacrificed at different time
points (n = 3–4 mice per time point; Figure 4A). We analyzed
the cell birth date by BrdU labeling and apoptosis by nuclear
morphology (Figures 4B–4E). We quantified the number of new-
born cells (BrdU-immunopositive [BrdU+]), the total number of
apoptotic cells (pyknotic), and the number of newborn apoptotic
cells (BrdU+ pyknotic) in confocal z-stacks, and then we calcu-
lated the number of those cells over the volume spanned by
the SGZ per hippocampus.
The number of BrdU+ cells reaches a peak at 2 days postinjec-
tion (dpi), decaying exponentially afterwards (R2 = 0.888, p <
0.0001; Figure 4B), in agreement with previous observations
(Kempermann et al., 2004; Kronenberg et al., 2003; Mandyam
et al., 2007). The decay is faster during 2–4 dpi (47–69 BrdU+
cells lost per hour, i.e., 0.8%–1.0% of the 2 dpi-BrdU+ cells perCell Stem Cell 7, 483–495hour) and slower during 8–15 dpi (0–11
BrdU+ cells lost per hour, i.e., 0%–0.2%
of the 2 dpi-BrdU+ cells per hour)
(Figure 4C). After 15 dpi, no significant
drop in the number of BrdU+ cells is
detected (p > 0.05; Figure 4B). The first
apoptotic BrdU+ cells appear 24 hr after
the BrdU administration and peak at
2 dpi (121 ± 33 cells/hippocampus),
accounting for 7.6% ± 3% of the total
number of apoptotic cells and 2.2% ±
0.8% of the total number of BrdU+ cells
at that time point (Figures 4D and 4E;
Table S3). These data provide evidencethat newborn cells undergo apoptosis, because the time course
of apoptotic BrdU+ cells parallels the decline of the BrdU+ cells.
Yet, despite the apparent match, the number of apoptotic SGZ
cells labeled with BrdU is strikingly low, compared to the total
number of apoptotic cells in the SGZ (Figure 4D). One possible
explanation is that the decrement in the number of BrdU+ cells
is due to BrdU dilution or alternatively, that a single pulse of
BrdU, which circulates approximately 15 min (Mandyam et al.,
2007), labels a fraction of the dividing NPC population, thus
decreasing the probability of detection of newborn apoptotic
cells.
To explore those two scenarios, we utilized a cumulative,
BrdU-saturating paradigm that consisted of repeated injections
of BrdU every 3 hr for a 24 hr period, as previously reported
(Hayes and Nowakowski, 2002) (n = 3–4 mice per time point;
Figure 5A). This approach allowed us to label the majority of
the cohorts of dividing cells over a 24 hr period and to relabel
each cohort two to three times (the estimated duration of the, October 8, 2010 ª2010 Elsevier Inc. 487
Figure 4. Survival of Newborn Cells in
a Single BrdU Injection Paradigm
(A) Experimental design showing a single injection
of BrdU at t = 0 and the different time points
studied thereafter (SAC = sacrifice time points).
(B) Left: quantification of the number of BrdU+ cells
along the time course of 32 days postinjection
(dpi). Statistical differences were assessed by
ANOVA (p < 0.001) followed by least significant
difference (LSD) tests comparing each time point
with all later time points. The maximum number
is reached at 2 dpi and decreases afterwards.
Starting from 15 dpi, no significant differences
are found with any of the later time points (ns).
Right: Photomicrographs of the 1 m.o. mouse
sections of the dentate gyrus at 2, 3, and 4 dpi
depict the decrease in the number of BrdU+ cells
in the SGZ.
(C) BrdU decay, quantified as percentage of the
cells at 2 dpi lost per hour.
(D) Apoptotic BrdU+ fraction, quantified as the
percentage of apoptotic cells labeled with BrdU
along the time course of 32 dpi. Apoptotic BrdU+
cells are mostly found between 1 and 3 dpi.
(E) Confocal photomicrograph of an apoptotic
(pyknotic) cell labeled with BrdU at 2 dpi (arrow-
head) and phagocytosed by microglia (M), shown
as a three-dimensional rendering (E1) and in
orthogonal projections of confocal z-stacks (E2).
(Same cell is shown in Figure S1E.)
Scale bars represent 50 mm in (B) (z = 20 mm) and
10 mm in (E). ND, nondetectable. Bars represent
mean ± SEM.
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Apoptosis/Phagocytosis in Hippocampal NeurogenesisS phase is approximately 8 hr) (Hayes and Nowakowski, 2002).
This labeling paradigm does not affect the number of apoptotic
cells, which remains stable regardless of the number of injec-
tions (Figure S4).
By using the cumulative BrdU labeling paradigm, we again
observed the decay in the number of newborn BrdU+ cells in
the young adult SGZ (Figure 5B). The maximum number of
BrdU+ cells is detected at the first time point studied, 27 hr post-
injection (1.1 dpi), after which the number of BrdU+ cells declines
at an exponential rate (R2 = 0.758, p < 0.0001). After 8 dpi, no
significant decline of BrdU+ cells is observed (p > 0.05) (Fig-
ure 5B). Interestingly, the rate of the BrdU+ cell decline per
hour is different at different time points. Initially, during the first
2 dpi, the decline occurs at a rate of 400 BrdU+ cells per hour
(2% of the 1.1 dpi-BrdU+ cells per hour), and then it drops to
20–80 BrdU+ cells per hour between 4 and 8 dpi (0.1%–0.4%
of the 1.1 dpi-BrdU+ cells per hour) (Figure 5C). Apoptotic
BrdU+ cells are detected throughout the time course and are488 Cell Stem Cell 7, 483–495, October 8, 2010 ª2010 Elsevier Inc.s
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particularly at 2 dpi (Figure 5D; Figure S4).
The apoptotic BrdU+ ratio is maximal
between 2 dpi and 4 dpi, when 32%–
33% of the apoptotic cells are labeled
with BrdU (460 ± 101 and 532 ± 19
apoptotic BrdU+ cells per hippocampus
at 2 dpi and 4 dpi, respectively) (Fig-
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igures 4C and 5C), a major contribution of BrdU dilution to the
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ercentage of apoptotic BrdU+ cells compared to the total
umber of BrdU+ cells suggests that these cells are rapidly
moved from the neurogenic niche, rendering them difficult to
etect and quantify. Our estimation (see Experimental Proce-
ures), based on the analysis of the decay between two consec-
tive time points, indicates that the clearance time is 1.2–1.5 hr
Figure 5. Survival of Newborn Cells in
a Cumulative BrdU Injection Paradigm
(A) Experimental design showing the injection of
BrdU every 3 hr for 24 hr and the different time
points studied after the first injection (SAC = sacri-
fice time points).
(B) Left: quantification of the number of BrdU+ cells
along the time course of 32 days postinjection
(dpi). Statistical differences were assessed by
ANOVA (p < 0.001) followed by LSD tests
comparing each time point with all later time
points. Starting from 11 dpi, no significant differ-
ences are found with any of the later time points
(ns). Right: Photomicrographs of the 1 m.o. mouse
sections of the dentate gyrus at 2, 4, and 6 dpi
depict larger number of BrdU+ cells labeled with
the cumulative BrdU paradigm compared to the
single BrdU paradigm, but still decreasing in
number over time.
(C) BrdU decay, quantified as percentage of the
cells at 2 dpi lost per hour.
(D) Apoptotic BrdU+ fraction, quantified as the
percentage of apoptotic cells labeled with BrdU
along the time course of 32 dpi. Apoptotic BrdU+
cells peak between 2 and 4 dpi.
(E) Confocal photomicrographs of the nestin-GFP
and POMC-EGFP expression in the early (3 dpi)
and late (8 dpi) critical periods, respectively.
(F) Quantification of the biomarker expression in
the early (3 dpi) and late (8 dpi) critical periods.
In the early critical period, apoptotic cells express
nestin-GFP and POMC-EGFP, whereas only
POMC-EGFP is expressed in the late critical
period.
Scale bars represent 50 mm in (B) (z = 20 mm) and
10 mm in (E). ND, nondetectable. Bars represent
mean ± SEM. See also Figure S4.
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At those time points, 92%–95%of the apoptotic cells are located
in the SGZ and only 5%–8% in the hilus, therefore suggesting
that the apoptotic newborn cells are not displaced, but rather
phagocytosed locally (Figure S4). Thus, the combination of a
high phagocytic index (about 91%, Figure 1D) and a short clear-
ance time suggests that microglia are very efficient in removing
the apoptotic corpses from the young adult SGZ neurogenic
niche.
Taken together, the above results indicate that themajor stage
of culling of newborn cells in the young adult SGZ occurs during
the first 1–4 days of cell life, when 56% of the newborn cells are
lost, the decay rate is high (400 cells/hr), and a high percentage
of apoptotic cells are BrdU+ (10%–33%). From 4 to 8 days of cell
life, another 25% of the newborn cells are lost; the decay rate is
low (20–80 cells/hr) and a low percentage of apoptotic cells are
BrdU+ (6%–8%). The second period of apoptosis could repre-
sent the decaying tail of the first apoptotic period, or it mightCell Stem Cell 7, 483–495represent a second wave of culling. After
11 dpi, no further loss of BrdU+ cells is
detected, although occasional apoptotic
BrdU+ cells are found. Given the rate of
the decay and the labeling of apoptotic
cells with BrdU, it thus appears that themain critical period for survival of the newborn cells during young
adult neurogenesis occurs within 4 days of cell birth.
To further explore the differences between the two criti-
cal periods, we analyzed the expression of two markers, nes-
tin-GFP and POMC-EGFP, at 3 dpi and 8 dpi, via the cumula-
tive BrdU labeling paradigm (Figures 5E and 5F; Figure S4).
In the early critical period (3 dpi), 28% ± 5% of the apoptotic
BrdU+ cells express nestin-GFP (12/42 apoptotic BrdU+ cells,
n = 4 mice) and 8% ± 2% express POMC-EGFP (3/42 apo-
ptotic BrdU+ cells, n = 3 mice), confirming our previous obser-
vation that in this period, the cells undergoing apoptosis are
in transition between ANPs (Nestin-GFP+) and NBs (POMC-
EGFP+). In the late critical period (8 dpi), none of the apoptotic
BrdU+ cells express nestin-GFP (0/3 apoptotic BrdU+ cells,
n = 3 mice) and 88% ± 13% express POMC-EGFP (5/6
apoptotic BrdU+ cells, n = 3 mice), indicating that more differ-
entiated NBs undergo apoptosis during this critical period of
survival., October 8, 2010 ª2010 Elsevier Inc. 489
Figure 6. Age-Dependent Decline in SGZ Apoptosis
(A) Photomicrographs of the hippocampal sections obtained from 1, 2, 5, and 12m.o. mouse demonstrate the decline in the number of NBs (PSA-NCAM+) and the
number of apoptotic profiles, identified by nuclearmorphology (pyknosis) and phagocytosis bymicroglia (Iba1+), pointed by arrows. Numbered insights represent
higher magnification of the identified apoptotic cells.
(B) Quantification of the number of apoptotic cells in the SGZ during adulthood. The number of SGZ apoptotic cells decreases sharply after 1 month of age.
(C) Quantification of the Ph-index. The microglial phagocytic efficiency remains constant throughout adulthood.
Scale bars represent 50 mm for low magnification (z = 16.24 mm) and 10 mm for high magnification. Bars represent mean ± SEM.
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Age-Induced Decrease of Neurogenesis
During aging, there is a well-reported decrease in hippocampal
neurogenesis largely attributable to decreased proliferation
(Kuhn et al., 1996). We therefore asked what happens with
apoptosis with increased age and whether the coupling between
apoptosis and phagocytosis in the adult SGZ persists during
age-induced decrease in neurogenesis. As we have shown,
the majority of the apoptotic cells in the young adult SGZ are490 Cell Stem Cell 7, 483–495, October 8, 2010 ª2010 Elsevier Inc.1–4 days old and express biomarkers of late ANPs/early NBs
(Figures 3–5). Our data, thus, predict a decrease in the number
of apoptotic cells in parallel with the decrease in SGZ neurogen-
esis and concomitantly with the increased age.
We analyzed both apoptosis and phagocytosis in the SGZ at 1,
2, 5, and 12m.o. (Figure 6; n = 4mice). Apoptotic cells were iden-
tified based on pyknosis, NBs with PSA-NCAM, and microglia
with Iba1. As expected, the number of PSA-NCAM + NBs as
well as the number of apoptotic cells in the SGZ decreases
Figure 7. Acute InflammationAffects Young
Adult SGZ Neurogenesis and Apoptosis
(A) Experimental paradigm for the study of the
effects of LPS (1 mg/kg), 8 hr or 22 hr, on the
neurogenic cascade. To study the LPS effect on
newborn cell survival, IdU was injected 2 days
before LPS. To study the LPS effect on cell prolif-
eration, CldU was injected 2 hr before the end of
the experiment (SAC = sacrifice time points).
(B) Quantification of the effects of LPS 8 hr (upper
panels) or 22 hr (lower panels) after treatment, on
the NPC proliferation (CldU+ cells), newborn cell
survival (IdU+ cells), apoptosis (pyknosis), and
Ph-index. SGZ apoptosis increases 8 hr after
LPS and is followed by a decreased survival
22 hr after LPS. Proliferation and Ph-index remain
unaffected.
(C) Representative examples of the proliferation,
survival, apoptosis, and phagocytosis in the young
adult mouse SGZ in control and LPS-treated
animals at 8 hr (C1, C2). A 3D rendering of a micro-
glial cell (8 hr after LPS) phagocytosing three
apoptotic cells is shown in (C3). The phago-
cytic capacity (percentage of microglia with 0–4
phagocytic profiles) is increased 8 hr after LPS
treatment (C4).
(D) Representative examples of the proliferation,
apoptosis, and phagocytosis in the young adult
mouse SGZ in control and LPS-treated animals
at 22 hr (D1, D2). See also Figure S5.
Scale bars represent 50 mm in (C1) and (C2)
(z = 20 mm); 5 mm in (C3); and 50 mm in (D) (z =
20 mm). Ph1-3, phagocytic processes. Bars repre-
sent mean ± SEM; *p < 0.05 (Student’s t test).
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remains constant in the ages studied (around 92%; Figure 6C;
Table S5), indicating that the microglial phagocytic activity is
preserved throughout adulthood. Interestingly, aging results in
chronic activation of microglia with increased production of
proinflammatory cytokines (Sierra et al., 2007). Even though
we have not analyzed the amount of cytokines produced by
microglia in our experiments, our data imply that throughout
adulthood microglia are equally efficient in phagocytosing apo-
ptotic cells in the SGZ neurogenic niche.
Microglial Phagocytic Activity Is Preserved during Acute
Neuroinflammation
Finally, we investigated whether an exogenous inflammatory
challenge known to activate the microglial inflammatory
response interfered with the SGZ phagocytosis. We induced
acute neuroinflammation by peripheral administration of LPSCell Stem Cell 7, 483–495(1 mg/kg), which stimulates microglia to
express proinflammatory cytokines that
peak at 3 hr and return to basal levels
by 24 hr (Sierra et al., 2007). Two inde-
pendent experiments were done to test
the short (8 hr) or long (22 hr) effect of
LPS (Figure 7; n = 4–5 mice per group).
To test the effect of the LPS on survival,
animals were injected with iodo-deoxyur-idine (IdU; 42.5 mg/kg) 2 days prior to the administration of LPS
or vehicle (Figure 7A). To test the effect of the LPS on NPC prolif-
eration, animals were injected with chloro-deoxyuridine (CldU;
57.5 mg/kg) 2 hr prior to sacrifice. We assessed the number
of IdU+ and CldU+ cells (by immunolabeling), apoptosis (by
nuclear morphology), and microglial engulfment (by Iba1 immu-
nolabeling).
No significant changes in NPC proliferation were observed,
either 8 or 22 hr after the LPS treatment, but we noted a signifi-
cant decrease in the survival of 2-day-old IdU+ cells 22 hr after
the LPS in the treated compared to control animals (40% ±
13% decrease; p = 0.0326, Student’s t test; Figures 7B and
7C; Figure S5). The decreased survival is most likely the result
of increased apoptosis early on, since in LPS-treated animals
8 hr thereafter, we find a 242% ± 44% increase in apoptotic cells
compared to control animals (p = 0.0166, Student’s t test). LPS,
after either 8 hr or 22 hr, failed to induce any detectable, October 8, 2010 ª2010 Elsevier Inc. 491
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number of apoptotic cells 8 hr after the LPS is cleared out by
the same number of microglial cells, and we frequently detected
microglia phagocytosing several apoptotic cells (Figure 7C3).
We calculated that the phagocytic capacity, i.e., the percentage
of microglia with multiple (0–4) phagocytic profiles, increases
2.41 times in LPS-treated versus control mice, 8 hr after the
administration of LPS (Figure 7C4). In control mice, microglia
has in average 0.35 phagocytic profiles per cell, and the major-
ity of them has none or one profile; whereas 8 hr after the
LPS, microglia has an average of 0.84 phagocytic profiles
per cell, and a significant percentage shows more than one
phagocytic profile per microglial cell (Figure 7C4). Remarkably,
either 8 or 22 hr after the LPS, the Ph-index remains constant
and around 90%–96% (Figure 7B; Table S6). Thus, these results
indicate that the phagocytic efficiency of microglia in the
young adult SGZ is not perturbed during acute inflammatory
challenge.
DISCUSSION
In the present study, we reveal novel properties of the cellular
niche that modulates young adult hippocampal neurogenesis.
First, we find that the decay in the number of newborn cells in
the young adult SGZ is due to apoptosis of newborn cells.
Second, the majority of apoptosis occurs within the first 1–
4 days of cell birth during the transition from late ANPs to early
NBs, suggesting that the main critical period for newborn cell
survival occurs very early in neurogenesis, in contrast to the
generalized assumption that survival is regulated at the imma-
ture neuron stage (Ma et al., 2009). Third, phagocytosis of the
apoptotic newborn cells is performed exclusively by ‘‘unchal-
lenged’’ microglia, indicating a novel, previously unrecognized
role of such microglia in the normal adult SGZ neurogenic niche
that has not been acknowledged in recent reviews (Ekdahl et al.,
2009; Neumann et al., 2009). Phagocytosis itself does not
appear to activate microglia in the same way an inflammatory
challenge does, contrary to the widespread view that activation
is a prerequisite for phagocytosis (Kettenmann, 2007). Phagocy-
tosis by unchallenged microglia involves the processes rather
than the cell body and is highly efficient, as measured by the
clearance time, the Ph-index, and the phagocytic capacity.
Microglial efficiency remains the same during adulthood and
acute inflammation, suggesting the importance of phagocytosis
for the maintenance of the functional neurogenic niche in both
health and disease.
The Majority of Newborn Cells Undergo Apoptosis
The disappearance of BrdU-labeled newborn cells in the adult
SGZ, particularly in the first week of cell life, was first described
by Kronenberg and collaborators (Kronenberg et al., 2003) and
has been shown bymany others (Kempermann et al., 2004;Man-
dyamet al., 2007). The decay of newborn cells after the first week
of life has also been observed via retroviral labeling of the
progeny of SGZ dividing cells (Tashiro et al., 2006), but the early
survival in such experiments has not been reported, because the
expression of the genes delivered by viral vectors generally takes
several days (Zhao et al., 2006). In contrast, genetic methods of
labeling, by means of a nestin-CreER promoter, showed an492 Cell Stem Cell 7, 483–495, October 8, 2010 ª2010 Elsevier Inc.accumulation of newborn cells (Lagace et al., 2007). Because
this method labels all nestin-expressing cells and their progeny,
not only the dividing ones, labeled cells accumulate as new
progenitors are recruited to the pool of dividing cells. Therefore,
to explain the decay of BrdU-labeled cells, two alternative expla-
nations have been proposed, namely, dilution of the BrdU
labeling by continuous NPC proliferation or death of the newborn
cells. Mathematical models disputed the BrdU dilution hypoth-
esis, showing that cell death has to occur in the first 72 hr to
explain the discrepancy between the expected and the actual
number of BrdU+ cells in the adult hippocampus, when using
a saturating BrdU-labeling paradigm (Hayes and Nowakowski,
2002). The prevailing view thus has been that SGZ newborn cells
die by apoptosis at the immature neuron stage (reviewed in
Ma et al., 2009). This assumption is based on the higher density
of apoptotic cells in neurogenic areas, including the SGZ,
compared to the rest of the brain (Biebl et al., 2000; Dayer
et al., 2003; Kuhn et al., 2005), as well as on occasional, non-
quantified colocalization of apoptotic markers with BrdU in the
adult SGZ (Dayer et al., 2003; Mandyam et al., 2007). More
recently, it was shown that constitutive overexpression of
the antiapoptotic protein Bcl-2 (Kuhn et al., 2005) or constitutive
deletion of the proapoptotic gene Bax (Sun et al., 2004)
increased SGZ neurogenesis, although these studies could
not discriminate between embryonic and adult effects. Taken
together, the published data have not compellingly demon-
strated the identity or the age of the apoptotic cells in the adult
SGZ neurogenic niche.
Herein, we provide evidence that the majority of young adult
SGZ newborn cells undergo apoptosis soon after they are
born. By comparing the decay rate of BrdU+ cells in the single
and the cumulative BrdU-labeling paradigms along the 1 month
time course, we exclude BrdU dilution as a major contributor to
the BrdU decay. More importantly, we provide direct evidence of
newborn cell apoptosis. The vast majority of apoptotic cells in
the young adult SGZ are newborn cells, as shown by the fact
that they are labeled with BrdU along the time course of the
cumulative paradigm. In addition, there is a conspicuous parallel
between the BrdU+ decay rate and the apoptotic BrdU+ fraction
along the evaluated time period, both in the cumulative and the
single BrdU-labeling paradigms. Notably, apoptosis is not an
artifact of the BrdU labeling, as indicated by the fact that the
number of SGZ apoptotic cells remains unchanged in control
versus BrdU-treated animals (both single and cumulative exper-
iments). Finally, our data predict that if apoptotic cells in the adult
SGZ are newborn cells, then rates of SGZ apoptosis should
parallel the proliferation rates, at least in experimental paradigms
where survival is not affected. In agreement with this prediction,
we find that with increased age, which causes a well-known
decrease in NPC proliferation (Kuhn et al., 1996), there is a signif-
icant decrease in the number of SGZ apoptotic cells. All these
lines of evidence strongly suggest that the decay in the number
of newborn cells labeled with BrdU can be explained by the
apoptosis of the newborn cells.
The Main Critical Period of Survival of Newborn Cells
Occurs Early in Cell Life
Our study also demonstrates that the critical period of survival of
young adult SZG newborn cells occurs soon after cell division,
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erating ANPs to early, postproliferative NBs. Adult SGZ newborn
cell survival has usually been studied at 2–4 weeks of cell life, at
the late NBs or immature neuron stages, when it is known to be
affected by animal behavior, neuronal activity, growth factors,
drugs of abuse, and hormones (Ma et al., 2009). For instance,
it has been suggested that NMDA receptor-dependent integra-
tion of the newborn neurons into the hippocampal circuitry deter-
mines the newborn cell survival in the third week of a cell life
(Tashiro et al., 2006). In agreement, we observe apoptotic cells
labeled with BrdU up to 3 weeks after BrdU injection, even
though the number of apoptotic cells we detect at this time is
small. Nonetheless, taking together our results and the published
literature, it is likely that there are two critical periods for newborn
cell survival in the young adult SGZ: a main, early critical period
(1–4 days after cell birth) and a secondary, late critical period
(1–3 weeks after cell birth). A similar scenario could also occur
in the other adult neurogenic system, in which neural precursors
residing in the subventricular zone give rise to NBs that migrate
through the rostral migratory stream (RMS) toward the olfactory
bulb (OB), where they differentiate into mature neurons and inte-
grate into the circuitry. Apoptosis has been observed in the RMS
as well as the OB (Petreanu and Alvarez-Buylla, 2002), perhaps
representing the early (RMS) and late (OB) critical periods of
survival. Similarly, an early critical period of survival is known
to occur during the embryonic brain development, when up to
70% of embryonic neuronal precursors undergo cell death early
after cell birth, independent of target innervation (Thomaidou
et al., 1997). However, the mechanisms regulating this early
survival as well as the clearance of apoptotic cells in the devel-
oping brain are not completely understood (de la Rosa and de
Pablo, 2000). We speculate that, since cell death occurs while
the cells are still in a highly proliferative stage, apoptosis and
mitosis could be functionally related. In fact, it has been recently
shown that during asymmetric NB division in C. elegans, the
same cellular machinery is responsible for both the orientation
of the cleavage plane during cell division and the induction
of apoptosis (Hatzold and Conradt, 2008). Thus, the early
apoptosis of newborn cells in the young adult SGZ may be due
to an evolutionarily conserved mechanism related to the mitosis
of neural precursors.
The pruning of adult newborn cells during an early critical
period of survival is a physiological mechanism whose occur-
rence in disease conditions remains to be studied. For instance,
seizures induce widespread necrosis and apoptosis of neurons
(Weise et al., 2005) as well as apoptosis of newborn cells within
the neurogenic niche (Ekdahl et al., 2001, 2002, 2003b).
However, it remains unknown which cell types within the neuro-
genic niche undergo seizure-induced apoptosis. We speculate
that newborn cells in different stages of maturation may have
different susceptibilities to seizure-induced apoptosis depend-
ing on the expression of glutamatergic receptors, which are
largely responsible for the seizure activity (Eid et al., 2008).
In the adult neurogenic niche, glutamate receptors are not
expressed until the immature neuron stage, coinciding with the
development of functional synaptic input (Nacher and McEwen,
2006). It is therefore possible that seizure-induced apoptosis
affects more mature newborn cells than the processes leading
to apoptosis of newborn cells in physiological conditions.CANovel Role for Microglia in the Adult Neurogenic Niche
Our results also demonstrate that shortly after undergoing apo-
ptosis, the SGZ newborn cells are phagocytosed and cleared
out by unchallenged microglia. Phagocytosis by macrophages
or activated, amoeboid microglia has been well documented
and is thought to occur in response to pathological events
(Kettenmann, 2007). In contrast, we herein show that in the
normal adult brain, phagocytosis is carried out by unchallenged
microglia, which show ramified morphology and have low
expression of markers typically associated with inflammatory
challenge, such as CD11b and CD68. Further, phagocytosis
by unchallenged microglia takes place through terminal or en
passant branches independent from the cell body. Microglial
cells are present in the normal hippocampal neurogenic niche
and sample it mostly through their processes, known to be highly
motile (Davalos et al., 2005). Importantly, contact by microglia
does not appear to be essential for the induction of apoptosis
in the adult SGZ; we consistently find a proportion of apoptotic
cells that are not engulfed. This observation does not exclude
a possible extrinsic influence of microglia on apoptosis, as has
been shown to occur during development (Neumann et al.,
2009).
Furthermore, our data suggest that phagocytosis by SGZ
microglia is efficient, as measured by the clearance time,
Ph-index, and phagocytic capacity, thus providing the first quan-
tified study of microglial phagocytosis in the adult brain. We esti-
mate that the clearance time is 1.2–1.5 hr per apoptotic cell. This
estimation is close to the range of estimatedmicroglial clearance
time in vitro (0.5–1.3 hr) (Petersen and Dailey, 2004) and the
clearance time in the developing cortex (2–3 hr) (Thomaidou
et al., 1997). Microglia also have a high Ph-index (about 91%–
94%), another indirect measure of their phagocytic efficiency.
The Ph-index remains constant (>90%) throughout normal neu-
rogenesis as well as during adulthood and acute neuroinflamma-
tion. Thus, the combination of a high phagocytic index and
a short clearance time suggests that microglia are very efficient
in removing the apoptotic corpses from the adult SGZ neuro-
genic niche. The high phagocytic efficiency of microglia explains
the difficulty in detecting and quantifying SGZ cells undergoing
apoptosis. More importantly, the preservation of the Ph-index
suggests a critical role of microglial phagocytosis in the mainte-
nance of the neurogenic cascade, because it prevents primary
apoptotic cells from undergoing secondary necrosis, with the
consequent spillage of cellular contents leading to an inflamma-
tory response (Savill et al., 2002), detrimental for neurogenesis
(Ekdahl et al., 2003a; Monje et al., 2003).
In conclusion, we have shown that unchallenged microglia are
an important component of the cellular neurogenic niche in the
SGZ of the adult hippocampus. Previous reports had indicated
either beneficial or detrimental effects of activated microglia on
SGZ neurogenesis, depending on the particular paradigm of
activation studied (Ekdahl et al., 2009). Initial reports suggested
that inflammation, resulting from activation of microglia by irradi-
ation or administration of high doses of LPS, is detrimental for
neurogenesis (Ekdahl et al., 2003a; Monje et al., 2003). In
contrast, later studies indicated a beneficial effect on neurogen-
esis of microglia activated by adrenalectomy (Battista et al.,
2006), cytokines (Butovsky et al., 2006), or enriched environment
(Ziv et al., 2006), but not by physical exercise (Olah et al., 2009).ell Stem Cell 7, 483–495, October 8, 2010 ª2010 Elsevier Inc. 493
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healthy adult neurogenic niche that is independent from the
state of activation of the microglial cell and on the level of
neurogenesis.
EXPERIMENTAL PROCEDURES
Animals
Wild-type (C57BL/6) or transgenic nestin-GFP (Mignone et al., 2004), nestin-
CFPNuc (Encinas et al., 2006), fms-EGFP (Sasmono et al., 2003), POMC-
EGFP (Overstreet et al., 2004), or hGFAP-GFP (Zhuo et al., 1997) mice were
used. All mouse studies were approved by the Baylor College of Medicine
Institutional Animal Care and Use Committee and performed in accordance
with institutional and federal guidelines.
Histology
Mice were transcardially perfused with saline and 50 ml of 4% paraformalde-
hyde. The brains were dissected out and sectioned with a vibratome. For
immunofluorescence, free-floating sections were immunolabeled according
to conventional procedures (Sierra et al., 2007). For ultrastructural analysis,
pre-embedding was used (Encinas and Enikolopov, 2008).
Confocal and Electron Microscopy
Sections were imaged with a Zeiss LSM or a Leica SP5 confocal microscope.
The number of apoptotic cells and/or BrdU+ cells per z-stack was estimated
via the optical dissector method (Encinas and Enikolopov, 2008). Blind anal-
ysis was performed with AxioVision 4.5 (Zeiss) or LAS AF Lite (Leica), and
3D rendering was performed with ImageSurfer (http://www.imagesurfer.org).
For electron microscopy, sections were imaged in a FEI BioIwinG2 Transmis-
sion Electron Microscope.
Statistics
Statistical analysis was performed with SPSS. Experiments involving two
groups were compared via unpaired Student’s t test. Experiments involving
more than two groups were compared by multiple-way analysis of variance
(ANOVA), followed by posthoc analysis with LSD (least significant difference).
Significancewas defined as p < 0.05. The clearance timewas calculated as the
percentage of apoptotic BrdU+ cells over the total BrdU+ cells that disap-
peared between two consecutive points, multiplied by the time in hours
between those two points (Barres et al., 1992).
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